Member Info for fatprofits

So I'm guessing some of tbe mzrgined long were stopped out.

The clever don't need it

The stupid should not use it.

Long on GSK coming it to results ?.

98%, thats right 98% were long.

That figure kindly provided by IG.

Under 12.80 for me if we get to that level.

Different views make a market, it may sometimes be

worth considering other perspectives, if only to convince you

that your particular outlook is the right one.

So there were some cautious posts on the GSK board

before today's FY results And

The GSK price is Down - 4.99% (at the time of this post)

on results

What is your point?.

A small amount.

Want to see the next update and reaction before adding in larger quantity.

UK, thaks for the clarification, appreciated.

Besides GSK, we post on completely different stocks.

It takes all of 2 seconds for anyone to check that.

I put him/her on Ignore having just read two
of those posts.

Market is forward looking.

AZN have 4/5 years of rapidly rising earnings ahead.

The point is yet again another clanger as the market is forward looking.

You can look at AZN consensus for 2021 and 2022,
future dividends are well covered from FY 2021.

What PE multiple does negative deserve?.

Drug, what about comments on the pharma pipeline?

If I can muster the enthusiasm will have a listen later,
or read the transcript.

Liked Andrew and saw him present a couple of times, always Impressed.

Emma, never warmed to her.

Look at the GSK EPS number from 5 years ago

then look at their guidance for FY 21 on EPS.

There is the answer to your question.

Try looking forward and no backwards.

FY 2021 EPS consensus for AZN is £3.57.

FY 2022 EPS consensus at just under £4.90.

I am a little cautious on the AZN SP reaction to
the next update.

The two companies are however chalk and cheese.

Neil, AZN have stated repeatedly they will Not make any commercial return.

Perhaps if you had cared for as many people dying of COVID-19
as my partner has over the last 10 months, you might appreciate
why we are incredibly fortunate to have vaccination options now.

May I suggest the Ignore function

If you prefer not to read my posts.

sharesaplenty, luck with your holding.

Y
I look for trading opportunities and bought
a very small amount back as mentioned.

I do occasionally give a Strong Buy rec when I consider
medium term risk/reward looks very attractive.

Poker, they should have provided more clarity.

The split is about one year away, it can't have been that difficult

to provide some guidance in advance, all be it one that may

alter dependent on business performance.

You are blinded to GSK's weaknesses.

There is absolutely No guarantee they will produce a

successful Covid-19 vaccine.

Just as you have ignored two recent pipeline failures.

Perhaps read the pharma trade press.

Will probably reget this.

What concerns me most are the recent drug failures that

I highlighted earlier this week.

We are likely near peak ViiV here and without that incredibly
successful JV, heaven knows where GSK would be now.

They need pipeline success- as in really need pipeline success.